[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Heat- killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group:0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group:0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19.Treatment Group 3\tPlacebo group:0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Control Intervention1: Heat Killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group: 0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19. Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group: 0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19. Treatment Group 3 Placebo group: 0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Heat- killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group:0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group:0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19.Treatment Group 3\tPlacebo group:0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Heat Killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group: 0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19. Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group: 0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19. Treatment Group 3 Placebo group: 0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "0.1ml;3;daily (3 days)", "treatment_id": 843, "treatment_name": "Mycobacterium indicus pranii", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "0.1ml;3;daily (one day)", "treatment_id": 843, "treatment_name": "Mycobacterium indicus pranii", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Heat- killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group:0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group:0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19.Treatment Group 3\tPlacebo group:0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Control Intervention1: Heat Killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group: 0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19. Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group: 0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19. Treatment Group 3 Placebo group: 0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Heat- killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group:0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group:0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19.Treatment Group 3\tPlacebo group:0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Heat Killed Mycobacterium w: Group 1-Heat killed Mycobacterium w suspension group: 0.3 ml of Mw daily (0.1 ml x3injections) intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19. Treatment Group 2-Heat killed Mycobacterium w suspension + placebo group: 0.3 ml of Mw (0.1 ml x 3 injections) intradermally at 3 different sites for 1 day followed by 0.3 ml (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for next 2 consecutive days along with standard therapy of COVID-19. Treatment Group 3 Placebo group: 0.3 ml daily (0.1 ml x 3 injections) of placebo intradermally at 3 different sites for 3 consecutive days along with standard therapy of COVID-19.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]